Bionik Laboratories Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Bionik Laboratories Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q1 2023.
Bionik Laboratories Corp. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $255K.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$255K	+$255K		Mar 31, 2023	10-K	2023-06-21
Q4 2022	$260K			Dec 31, 2022	10-Q	2023-02-08
Q3 2022	$265K			Sep 30, 2022	10-Q	2022-11-09
Q1 2022	$0			Mar 31, 2022	10-K	2023-06-21

Showing 1 to 4 of 4 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.